China Blood Pressure Lowering Trelagliptin Succinate Powder Pharmaceutical Trelagliptin Succinate Material Trelagliptin Succinate, Find details about China Trelagliptin Succinate, Material Trelagliptin Succinate from Blood Pressure Lowering Trelagliptin Succinate Powder Pharmaceutical Trelagliptin Succinate Material Trelagliptin Succinate
Product name | Trelagliptin succinate |
CAS | 1029877-94-8 |
Appearance | white powder |
Assay | 99% |
Trelagliptin succinate (SYR-472) is a selective, long acting dipeptidyl peptidase-4 (DPP-4) inhibitor. An antidiabetic agent.
Orally active DPP-4 inhibitor that produces clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. SYR472 has a long duration of action and is well tolerated in clinical studies.
Trelagliptin succinate the world's first weekly oral DPP 4 inhibitors, used in type 2 diabetes, this product is a weekly dipeptide base peptidase IV (DPP - 4) inhibitors, through selective, sustained suppression DPP - 4, control blood sugar levels. DPP - 4 is an enzyme that can cause intestinal glucagon like peptide 1 (glp-1) promote and glucose dependence polypeptide (GIP) inactivation, and these two im down plays an important role in regulating blood sugar. Inhibiting dd-4 can increase blood glucose levels dependent on secretion, which can control blood glucose levels.
Generally, adults take orally SYR-472 100mg once a week.